(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global bioburden testing market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 14.3% during the forecast period. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.
Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.
Bioburden Testing Market Report Highlights

• On the basis of product, consumables segment dominated the market in 2023 owing to a wide use of culture media and reagents and kits.
• The PCR instruments facilitate rapid analysis of bacterial bioburden, thus, fostering high market growth.
• The aerobic count-testing held largest market share in 2023 due to easy isolation of aerobic bacteria by culture media.
• Raw material testing is anticipated to showcase lucrative growth during the forecast period owing to the increasing number of product recalls and concern regarding product quality.
• On the basis of end-use, pharmaceutical and biotechnology companies dominated the market in 2023 owing to the high growth of this industry.
• The number of CMOs is increasing significantly, which has led to a rise in outsourcing services, thus, driving the segment growth.
• North America held the largest revenue share in 2023 due to high R&D spending by key companies and high healthcare spending in the U.S.

The leading players in the Bioburden Testing market include:

• Charles River Laboratories
• Merck KGaA
• SGS Societe Generale de Surveillance SA.
• WuXi AppTec
• BD
• North American Science Associates, LLC
• Nelson Laboratories, LLC
• Thermo Fisher Scientific Inc
• BIOMERIEUX
• Pacific Biolabs

Key Attributes:

Report Attribute	Details
No. of Pages	100
Forecast Period	2023 - 2030
Estimated Market Value (USD) in 2023	$1.28 Billion
Forecasted Market Value (USD) by 2030	$3.22 Billion
Compound Annual Growth Rate	14.3%
Regions Covered	Global

Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Research Scope and Assumptions
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Bioburden Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Bioburden Testing Market Analysis Tools
3.4.1. Porter's Analysis
3.4.2. PESTEL Analysis
Chapter 4. Bioburden Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bioburden Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.1. Culture Media
4.3.1.2. Reagents and Kits
4.4. Instruments
4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.1. Automated Microbial Identification Systems
4.4.1.2. PCR Instruments
Chapter 5. Bioburden Testing Market: Test Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bioburden Testing Market: Test Movement Analysis, 2023 & 2030 (USD Million)
5.3. Aerobic Count Testing
5.4. Anaerobic Count Testing
5.5. Fungi/Mold Count Testing
5.6. Spore Count Testing
Chapter 6. Bioburden Testing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Bioburden Testing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Raw Material Testing
6.3.1. Raw Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Medical Device Testing
6.5. In-Process Material Testing
6.6. Sterilization Validation Testing
6.7. Equipment Cleaning Validation
Chapter 7. Bioburden Testing Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Bioburden Testing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Medical Device Manufacturers
7.5. Contract Manufacturing Organizations
7.6. Manufacturers of Food & Beverage and Agricultural Products
7.7. Microbial Testing Laboratories
Chapter 8. Bioburden Testing Market: Regional Estimates & Trend Analysis
8.1. Bioburden Testing Market Share, By Region, 2023 & 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Participant's Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Developments/ Strategic Initiatives

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Bioburden Testing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN21112024004107003653ID1108911650